Stem cell transplants play a vital role in treating people affected by blood cancers and disorders such as thalassemia.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

its gene-editing treatment for sickle cell disease and beta-thalassemia. Analysts responded positively to the results. According to The Fly, Barclays raised its price target on Vertex to $467 from ...

CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...

Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

Kanchi Kamakoti CHILDS Trust Hospital introduces pet therapy in PICU to support critically ill children's psychological ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.